Rituximab

From WikiMD.org
Jump to navigation Jump to search
Rituximab
TermRituximab
Short definitionRituximab - (pronounced) (rih-TUK-sih-mab) drug used alone or with other drugs under the brand names Riabni, Rituxan, Ruxience, and Truxima to treat certain types of B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and acute B-cell leukemia who are CD20 positive. Rituximab is also being studied to treat other diseases and cancers. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Rituximab - (pronounced) (rih-TUK-sih-mab) drug used alone or with other drugs under the brand names Riabni, Rituxan, Ruxience, and Truxima to treat certain types of B-cell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and acute B-cell leukemia who are CD20 positive. Rituximab is also being studied to treat other diseases and cancers. Rituximab attaches to a protein called CD20, which is found on B cells (a type of white blood cell) and some types of cancer cells. This can help the immune system kill cancer cells. Rituximab is a type of monoclonal antibody

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski